Recombinant human FSH and recombinant human LH in a 2:1 ratio combination: A new tool for ovulation induction

Expert Review of Obstetrics and Gynecology

Volumn 4, Issue 5, 2009, Pages 491-498

  Bosch, Ernesto ^a  

^a INSTITUTO VALENCIANO DE INFERTILIDAD   (Spain)

Author keywords

FSH; hypogonadotrophic hypogonadism; LH; ovulation induction

Indexed keywords

EID: 79960348181     PISSN: 17474108     EISSN: 17474116     Source Type: Journal    
DOI: 10.1586/eog.09.34     Document Type: Article

References (36)

1. Reame NE, Sauder ED, Case GD, Kelch RP, Marshall JC. Pulsatile gonadotropin secretion in women with hypothalamic amenorrhea: evidence that reduced frequency of gonadotropin releasing hormone secretion is the mechanism of persistant anovulation. J. Clin. Endocrinol. Metab. 61, 851-858 (1985). (Pubitemid 16218480)
2. Couzinet B, Lestrat N, Brailly S, Forest M, Schaison G. Stimulation of ovarian follicular maturation with pure follicle stimulating hormone in women with gonadotropin deficiency. J. Clin. Endocrinol. Metab. 66, 552-556 (1988). (Pubitemid 18076002)
3. Ryan RJ, Charlesworth MC, McCormick DJ, Milius RP, Keutmann HT. The glycoprotein hormones: recent studies of structure-function relationships. FASEB J. 2, 2661-2669 (1988)
4. Driebergen R, Baer G. Quantification of follicle stimulating hormone (follitropin α): is in vivo bioassay still relevant in the recombinant age? Curr. Med. Res. Opin. 19, 41-46 (2003). (Pubitemid 36378319)
5. Bassett RM, Driebergen R. Continued improvements in the quality and consistency of follitropinα recombinant human FSH. Reprod. Biomed. Online 10, 169-177 (2005). (Pubitemid 40246630)
6. Liu HC, He Z, Rosenwaks Z. In vitro culture and in vitro maturation of mouse preantral follicles with recombinant gonadotropins. Fertil Steril. 77, 373-383 (2002). (Pubitemid 34083562)
7. Karnitis VJ, Townson DH, Friedman CI, Danforth DR. Recombinant human follicle-stimulating hormone stimulates multiple follicular growth, but minimal estrogen production in gonadotropinreleasing hormone antagonist-treated monkeys: examining the role of luteinizing hormone in follicular development and steroidogenesis. J. Clin. Endocrinol. Metab. 79, 91-97 (1994).
8. The European Recombinant Human LH Study Group. Recombinant human luteinizing hormone (LH) to support recombinant follicle stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose finding study. J. Clin. Endocrinol. Metab. 83, 1507-1514 (1998).
9. Porchet HC, le Cotonnec JY, Loumaye E. Clinical pharmacology of recombinant human follicle-stimulating hormone. III. Pharmacokinetic- pharmacodynamic modeling after repeated subcutaneous administration. Fertil Steril. 61, 687-695 (1994). (Pubitemid 24114361)
10. le Cotonnec JY, Porchet HC, Beltrami V, Khan A, Toon S, Rowland M. Clinical pharmacology of recombinant human follicle-stimulating hormone (FSH). I. Comparative pharmacokinetics with urinary human FSH. Fertil Steril. 61, 669-678 (1994) (Pubitemid 24114359)
11. le Cotonnec JY, Porchet HC, Beltrami V, Munafo A. Clinical pharmacology of recombinant human luteinizing hormone: part I. Pharmacokinetics after intravenous administration to healthy female volunteers and comparison with urinary human luteinizing hormone. Fertil Steril. 69, 189-194 (1998).
12. le Cotonnec JY, Porchet HC, Beltrami V, Munafo A. Clinical pharmacology of recombinant human luteinizing hormone: part II. Bioavailability of recombinant human luteinizing hormone assessed with an immunoassay and an in vitro bioassay. Fertil Steril. 69, 195-200 (1998).
13. le Cotonnec JY, Loumaye E, Porchet HC, Beltrami V, Munafo A. Pharmacokinetic and pharmacodynamic interactions between recombinant human luteinizing hormone and recombinant human follicle-stimulating hormone. Fertil Steril. 69, 201-209 (1998). (Pubitemid 28117094)
14. Picard M, Rossier C, Papasouliotis O, Lugan I. Bioequivalence of recombinant human FSH and recombinant human LH in a fixed 2:1 combination: two Phase I, randomized, crossover studies. Curr. Med. Res. Opin. 24, 1199-208 (2008). (Pubitemid 351579179)
15. Balasch J, Miró F, Burzaco I et al. The role of luteinizing hormone in human follicle development and oocyte fertility: evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormone. Hum. Reprod. 10, 1678-1683 (1995).
16. Mochtar MH, Van der Veen, Ziech M, van Wely M. Recombinant luteinizing hormone (rLH) for controlled ovarian hyperstimulation in assisted reproductive cycles. Cochrane Database Syst Rev. 18(2), CD005070 (2007).
17. Chappel SC, Howles C. Reevaluation of the roles of luteinizing hormone and folliclestimulating hormone in the ovulatory process. Hum. Reprod. 6, 1206-1212 (1991).
18. Kolibianakis EM, Collins J, Tarlatzis B, Papanikolaou E, Devroey P. Are endogenous LH levels during ovarian stimulation for IVF using GnRH analogues associated with the probability of ongoing pregnancy? A systematic review. Hum. Reprod. Update. 12, 3-12 (2006). (Pubitemid 43013742)
19. Marrs R, Meldrum D, Muasher S, Schoolcraft W, Werlin L, Kelly E. Randomized trial to compare the effect of recombinant human FSH (follitropin2011) with or without recombinant human LH in women undergoing assisted reproduction treatment. Reprod. Biomed. Online 8, 175-182 (2004). (Pubitemid 38208463)
20. Humaidan P, Bungum M, Bungum L, Yding Andersen C. Effects of recombinant LH supplementation in women undergoing assisted reproduction with GnRH agonist down-regulation and stimulation with recombinant FSH: an opening study. Reprod. Biomed. Online 8, 635-643 (2004). (Pubitemid 38744939)
21. Fábregues F, Creus M, Peñarrubia J, Manau D, Vanrell JA, Balasch J. Effects of recombinant human luteinizing hormone supplementation on ovarian stimulation and the implantation rate in down-regulated women of advanced reproductive age. Fertil Steril. 85, 925-931 (2006).
22. Nyboeandersen A, Humaidan P, Fried G et al; Nordic LH Study Group. Recombinant LH supplementation to recombinant FSH during the final days of controlled ovarian stimulation for in vitro fertilization. A multicentre, prospective, randomized, controlled trial. Hum. Reprod. 23, 427-434 (2008). (Pubitemid 351651237)
23. Griesinger G, Schultze-Mosgau A, Dafopoulos K et al. Recombinant luteinizing hormone supplementation to recombinant follicle-stimulating hormone induced ovarian hyperstimulation in the GnRH-antagonist multiple-dose protocol. Hum. Reprod. 20, 1200-1206 (2005). (Pubitemid 40790242)
24. Cédrin-Durnerin I, Grange-Dujardin D, Laffy A et al. Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI cycles: a prospective randomized study. Hum. Reprod. 19, 1979-1984 (2004). (Pubitemid 39242642)
25. Levi-Setti PE, Cavagna M, Bulletti C. Recombinant gonadotrophins associated with GnRH antagonist (cetrorelix) in ovarian stimulation for ICSI: comparison of r-FSH alone and in combination with r-LH. Eur. J. Obstet. Gynecol. Reprod. Biol. 1(126), 212-216 (2006). (Pubitemid 43766308)
26. Lisi F, Rinaldi L, Fishel S, Lisi R, Pepe GP, Picconeri MG. Use of recombinant follicule-stimulating hormone (Gonal F) and a recombinant luteinizing hormone (Luveris) in multiple follicular stimulation in patients with a suboptimal response to in vitro fertilization. Fertil Steril. 79, 1037-1038 (2003). (Pubitemid 36385035)
27. Ferraretti AP, Gianaroli L, Magli MC, D'angelo A, Farfalli V, Montanaro N. Exogenous luteinizing hormone in controlled ovarian hyperstimulation for assisted reproduction techniques. Fertil Steril. 82, 1521-1526 (2004). (Pubitemid 39611376)
28. De Placido G, Alviggi C, Perino A et al.; Italian Collaborative Group on Recombinant Human Luteinizing Hormone. Recombinant human LH supplementation versus recombinant human FSH (rFSH) step-up protocol during controlled ovarian stimulation in normogonadotrophic women with initial inadequate ovarian response to rFSH. A multicentre, prospective, randomized controlled trial. Hum. Reprod. 20, 390-396 (2005). (Pubitemid 40277606)
29. De Placido G, Mollo A, Clarizia R, Strina I, Conforti S, Alviggi C. Gonadotropinreleasing hormone (GnRH) antagonist plus recombinant luteinizing hormone vs. a standard GnRH agonist short protocol in patients at risk for poor ovarian response. Fertil Steril. 85, 247-250 (2006). (Pubitemid 43063461)
30. Klein NA, Battaglia DE, Fujimoto VY, Davis GS, Bremner WJ, Soules MR. Reproductive aging: accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older women. J. Clin. Endocrinol. Metab. 81, 1038-1045 (1996). (Pubitemid 26083969)
31. Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: changes with age, menopause, and oophorectomy. J. Clin. Endocrinol. Metab. 90, 3847-3853 (2005). (Pubitemid 41058142)
32. Coomarasamy A, Afnan M, Cheema D, van der Veen F, Bossuyt PM, van Wely M. Urinary hMG versus recombinant FSH for controlled ovarian hyperstimulation following an agonist long down-regulation protocol in IVF or ICSI treatment: a systematic review and meta-analysis. Hum. Reprod. 23, 310-315 (2008). (Pubitemid 351651234)
33. Bosch E, Vidal C, Labarta E, Simon C, Remohí J, Pellicer A. Highly purified hMG versus recombinant FSH in ovarian hyperstimulation with GnRH antagonists - a randomized study. Hum. Reprod. 23(10), 2346-2351 (2008).
34. Bosch E, Pau E, Albert C, Zuzuarregui JL, Remohí J, Pellicer A. Impact of LH administration on oocyte quality and embryo morphology. Fertil Steril. 86(Suppl. 2), S425 (2006).
35. EMEA. Summary of product characteristics www.emea.europa.eu/humandocs/ PDFs/EPAR/pergoveris/H-714-PI-en.pdf
36. EMEA. Scientific discussion www.emea.europa.eu/humandocs/PDFs/EPAR/ pergoveris/H-714-en6.pdf